Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Bernardo Bonanni

Showing results (181-190 of 247) with videos related to

Pageof 25
Sort By:
Human Molecular Genetics|April 26, 2012
The role of genetic breast cancer susceptibility variants as prognostic factorsPeter A Fasching, Paul D P Pharoah, Angela Cox, et al.
European Journal of Cancer (Oxford, England : 1990)|August 7, 2022
Incorporating progesterone receptor expression into the PREDICT breast prognostic modelIsabelle Grootes, Renske Keeman, Fiona M Blows, et al.
Oncotarget|December 22, 2017
<i>PHIP</i> - a novel candidate breast cancer susceptibility locus on 6q14.1Xiang Jiao, Christos Aravidis, Rajeshwari Marikkannu, et al.
Plos Medicine|August 24, 2016
Genetically Predicted Body Mass Index and Breast Cancer Risk: Mendelian Randomization Analyses of Data from 145,000 Women of European DescentYan Guo, Shaneda Warren Andersen, Xiao-Ou Shu, et al.
Eclinicalmedicine|May 14, 2023
Mortality by age, gene and gender in carriers of pathogenic mismatch repair gene variants receiving surveillance for early cancer diagnosis and treatment: a report from the prospective Lynch syndrome databaseMev Dominguez-Valentin, Saskia Haupt, Toni T Seppälä, et al.
Human Genetics|May 21, 2011
Haplotype structure in Ashkenazi Jewish BRCA1 and BRCA2 mutation carriersKate M Im, Tomas Kirchhoff, Xianshu Wang, et al.
Breast (Edinburgh, Scotland)|November 12, 2025
Large-scale meta-analysis and precision functional assays identify FANCM regions in which PTVs confer different risks for ER-negative and triple-negative breast cancerAmandine Billaud, Gisella Figlioli, Clémence Mooser, et al.
JAMA Oncology|July 3, 2020
Characterization of the Cancer Spectrum in Men With Germline BRCA1 and BRCA2 Pathogenic Variants: Results From the Consortium of Investigators of Modifiers of BRCA1/2 (CIMBA)Valentina Silvestri, Goska Leslie, Daniel R Barnes, et al.
Human Mutation|February 21, 2018
The BRCA2 c.68-7T > A variant is not pathogenic: A model for clinical calibration of spliceogenicityMara Colombo, Irene Lòpez-Perolio, Huong D Meeks, et al.
International Journal of Epidemiology|December 13, 2017
Body mass index and breast cancer survival: a Mendelian randomization analysisQi Guo, Stephen Burgess, Constance Turman, et al.
Pageof 25

Showing results (181-190 of 247) with videos related to

Sort By:
Pageof 25
Human Molecular Genetics|April 26, 2012
The role of genetic breast cancer susceptibility variants as prognostic factorsPeter A Fasching, Paul D P Pharoah, Angela Cox, et al.
European Journal of Cancer (Oxford, England : 1990)|August 7, 2022
Incorporating progesterone receptor expression into the PREDICT breast prognostic modelIsabelle Grootes, Renske Keeman, Fiona M Blows, et al.
Oncotarget|December 22, 2017
<i>PHIP</i> - a novel candidate breast cancer susceptibility locus on 6q14.1Xiang Jiao, Christos Aravidis, Rajeshwari Marikkannu, et al.
Plos Medicine|August 24, 2016
Genetically Predicted Body Mass Index and Breast Cancer Risk: Mendelian Randomization Analyses of Data from 145,000 Women of European DescentYan Guo, Shaneda Warren Andersen, Xiao-Ou Shu, et al.
Eclinicalmedicine|May 14, 2023
Mortality by age, gene and gender in carriers of pathogenic mismatch repair gene variants receiving surveillance for early cancer diagnosis and treatment: a report from the prospective Lynch syndrome databaseMev Dominguez-Valentin, Saskia Haupt, Toni T Seppälä, et al.
Human Genetics|May 21, 2011
Haplotype structure in Ashkenazi Jewish BRCA1 and BRCA2 mutation carriersKate M Im, Tomas Kirchhoff, Xianshu Wang, et al.
Breast (Edinburgh, Scotland)|November 12, 2025
Large-scale meta-analysis and precision functional assays identify FANCM regions in which PTVs confer different risks for ER-negative and triple-negative breast cancerAmandine Billaud, Gisella Figlioli, Clémence Mooser, et al.
JAMA Oncology|July 3, 2020
Characterization of the Cancer Spectrum in Men With Germline BRCA1 and BRCA2 Pathogenic Variants: Results From the Consortium of Investigators of Modifiers of BRCA1/2 (CIMBA)Valentina Silvestri, Goska Leslie, Daniel R Barnes, et al.
Human Mutation|February 21, 2018
The BRCA2 c.68-7T > A variant is not pathogenic: A model for clinical calibration of spliceogenicityMara Colombo, Irene Lòpez-Perolio, Huong D Meeks, et al.
International Journal of Epidemiology|December 13, 2017
Body mass index and breast cancer survival: a Mendelian randomization analysisQi Guo, Stephen Burgess, Constance Turman, et al.
Pageof 25